I
Integrated Biosciences
Biotech & Life Sciences · San Carlos, United States · Founded 2022
Combining synthetic biology and machine learning to regulate cellular stress responses, the company develops next-generation therapeutics MoreLess
Integrated Biosciences is a biotechnology company that is pioneering the use of synthetic biology and machine learning to develop next-generation therapeutics for age-related diseases. The company's integrated discovery platform combines synthetic biology, AI-driven small-molecule drug discovery, optogenetics, chemistry, and computation to unravel complex biology and target cellular stress responses associated with conditions like neurodegeneration, cancer, and diabetes.
Integrated Biosciences operates in the biotechnology and pharmaceutical markets, with a focus on the development of drugs to treat age-related illnesses. The company's business model is centered around research and development, with the goal of discovering and developing new drugs that can be commercialized. The company has recently secured $17 million in funding to accelerate the development of its drug pipeline.
Keywords: biotechnology, synthetic biology, AI, machine learning, drug discovery, age-related diseases, cellular stress, therapeutics, small molecules, optogenetics
Company overview
Integrated Biosciences company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2022
- Headquarters
- San Carlos, United States
- Employees
- 17
- Open positions
- 3
- Dealroom signal
- 91.5
Valuation & funding
Integrated Biosciences funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Aug 2026 | $68M | $274M | Undisclosed | ↗ |
| SEED✓Equity / VC | Oct 2024 | $17M | $69M | Michael Stoppelman · Overlap Holdings · Sutter Hill Ventures · Vijay Pandurangan | ↗ |
| SEEDEquity / VC | Sep 2022 | $0 | — | Reinforced Ventures | — |
| SPINOUT✓Other financing | Jan 2022 | $0 | — | Massachusetts Institute of Technology · University of California, Santa Barbara | — |
Financials
Workforce over time
Available workforce history. Financial fields without reported data are omitted.
| Year | Employees |
|---|---|
| 2026 | 17 |
| 2025 | 16 |
| 2024 | 9 |
Growth signals
Integrated Biosciences website traffic
Latest recorded traffic for Integrated Biosciences is 8.5K monthly website visits, up 42400% over the last three months. Integrated Biosciences's team grew 6.3% over the past year.
Hiring
Open positions at Integrated Biosciences
Current openings linked to this company in Dealroom.
Comparisons
Integrated Biosciences compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Integrated Biosciences's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Integrated Biosciences has talent and traffic
team presence
In the news
Latest news about Integrated Biosciences
Recent press, funding announcements, and product moves mentioning Integrated Biosciences — open to read from the original sources.
Market sentiment
What the market is saying about Integrated Biosciences
An AI-synthesized read of the highest-engagement posts about Integrated Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Integrated Biosciences’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.